Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Tryp Therapeutics Inc. (TRYPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2298-0.0002 (-0.09%)
At close: 03:54PM EST
Advertisement
Sign in to post a message.
  • B
    Bawee
    Patience with this one. If they can help those with fibromyalgia, this alone will moon this stock. Buy and come back 5 months later.
  • V
    V
    This company has a lot of potential, can’t figure out why it keeps dropping..
    Bullish
  • B
    Billy
    Just bought my first shares... Let's goooo.. Hopefully this board fills up one day
  • w
    wahibThe🐐
    This stock will soar exactly like MMED. Both are the most advance psychedelic stocks in terms of research/FDA.
    Bullish
  • X
    Xavier
    this is going to the moon faster than gme
  • A
    Alex
    I have to be honest I sold $TRYP at $1.20 after 100% gain but I took it all and put it back in at $0.90 today. It really is one of the best companies in the #psilocybin and #psychedelic sector.
    TRYP is lean, cashed up, has ongoing trials, and is ready to capture the most value at the proof of concept phase of the drug development cycle = I’m seeing multiples.
  • A
    Alex
    TRYP is the most undervalued #psychedelic stock rn IMO. They have one of the only clear and certain methods towards monetization of #psilocybin drug development through proof of concept. When $TRYP is able to verify the beneficial applications of the multiple different drugs they have in trials right now this could be set for NASDAQ. Massive opportunity here. It is a steal at $0.80 IMO.
  • R
    Ryan
    Guys...this just came out today. Be careful they always spike on the first day then crash back down. These are fact..just wait.
  • H
    Harris
    TRYP is one of my favourite companies in the psychedelic sector. With their research into the use of psilocybin for diseases/disorders with unmet medical treatments, I can see the stock breaking into $1.00 levels once again soon. As the market rebounds, I believe that TRYP will be able to push to all-time highs in the future as they announce more good news!
  • j
    jason
    I will take a position in this stock but not at this valuation. It will drop after the initial hype like everyone prior
  • T
    T Crown
    Highly undervalued here. This is close to other names like $NUMI $CYBN $FTRP which means $TRYP should be $3+
  • A
    Alex
    There’s a lot of fluff in psychedelics rn. A lot of value is in R&D rn and therefore looking at the companies with the best scientists is key. TRYP has the best IMO. I’ll be buying Monday.
  • I
    Israel
    Where do I buy this stock?
  • T
    Tony
    Is this going to gain momentum this year i wonder?
  • R
    Riordan
    First
  • D
    Dante
    Get in now or forever hold your peace
  • A
    Alex
    TRYP continues to bolster their board and senior management with big additions like today. Their management have a history of #NASDAQ listings ( $IPA) is that where this could be going? + Genzyme (Where Mr.McKee held management positions) was Focused on Orphan Drugs as well. Now that $TRYP has made indications that this is also their plan I expect McKee will definitely help them get there. Loading at these levels.
  • D
    Dante
    going to 1.40
  • T
    Tony
    Is there any reason for the move up today ?
  • H
    Harris
    The stock hit the 6-month support levels and was unable to break through showing strong technical support at the $0.59 and $0.60 range. $TRYP is looking like it's beginning to gear up for another leg upwards, I'm adding more shares at these levels because I believe that their research TRP-8802 for fibromyalgia will prove to be especially effective during the phase 2a trials.
Advertisement
Advertisement